 | Inhibrx, Inc. | |||
| NGM : INBX || Location: United States | ||||
$34.09-0.29 (-0.84%) |
0.17 M | 34.02 - 34.22 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.200 M |
| March 28, 2024 | 2.152 M |
| March 15, 2024 | 1.600 M |
| Feb. 29, 2024 | 1.947 M |
| Feb. 15, 2024 | 2.103 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.06 | -1.73 | -63.61% |
| 09/30/2023 | -1.03 | -1.10 | -6.78% |
| 06/30/2023 | -1.05 | -1.08 | -2.50% |
| 03/31/2023 | -0.86 | -1.12 | -30.10% |
| 12/31/2022 | -0.80 | -0.95 | -18.19% |
INBX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 47.392M | Shares Float | 21.982M |
| Short Float | 2.200M | Market Cap | 1629.34M |
| Institution ownership | 86.55% | Insider ownership | 19.568% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -5.12 | Forward EPS | -4.00 |